[Drug metabolism in early life].
For various reasons the dosage of drugs in early life is difficult and complicated. Besides differences in sensitivity of pharmacological receptors, in protein binding of drugs and in drug distribution the metabolic elimination of drugs has to be considered as playing an important role for the understanding of the pharmacotherapeutic peculiarities of the perinatal period. The most important means for chemical inactivation of drugs are oxidation and conjugation of these foreign compounds. Both pathways will be briefly outlined. Evidence for a decreased ability of infants to oxidize drugs can be found in the observation that the biological half lives of amobarbital and other drugs are about twice as long as those of the mother. Retarded conjugation in infants manifests itself especially with sulfonamides. The postnatal development of the drug oxidizing enzyme system is described with special emphasis on the development of cytochrome P450 in young pigs. In this context it is of interest that the apoenzyme of the mixed function hydroxylase seems to be present already before the iron containing haem moiety is fitted into the enzyme molecule. Furthermore it is described that the postnatal development of the glucuxonyl transferase is different for different substrates.
D000654:Amobarbital / Q000378:metabolism; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D006207:Half-Life; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism*; D011485:Protein Binding; D011955:Receptors, Drug; D013449:Sulfonamides / Q000378:metabolism; D013552:Swine / Q000378:metabolism
D004364:Pharmaceutical Preparations; D011955:Receptors, Drug; D013449:Sulfonamides; D003577:Cytochrome P-450 Enzyme System; D000654:Amobarbital
Besonderheiten des Arzneimittelstoffwechsels beim Neugeborenen und jungen Säugling